This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Identify the credit card that offers the best cash back for gas purchases. Fuel your savings while you fill up your tank.
27,962 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Lucid Group has faced a tough year, with its stock down dramatically. This article breaks down the reasons behind the...
Investing in semiconductors means weighing two heavyweight names: Intel and TSMC. This guide breaks down the landscap...
Pricing power has long been Apple’s ace. Now the company faces a no-win pricing trap: raise prices risking demand, or...
Dividend income can be a steady stream, but payouts can change. This article flags three dividend stocks that could c...
As the Fed holds rates, income-focused investors seek reliable yields. This article highlights two dividend stocks ev...
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Cathie Wood's bold bets launched a new era for ETFs. This piece explains how ARK helped fuel demand for active ETFs, ...
Could short squeeze coming for Plug Power stock be the catalyst investors have been waiting for? This article breaks ...
IBM and Oracle have quietly strengthened AI backlogs and earnings, setting up a potential late-2026 surprise as marke...
OpenAI's Sam Altman and Anthropic's Dario Amodei are dialing back their earlier fears about AI wiping out white-colla...
Apple stock nears all-time as strong earnings and a growing Services business lift investor optimism. Here’s the late...